AGL
agilon health·NYSE
--
--(--)
--
--(--)
4.78 / 10
Netural
Fund flow is strong (7.95/10), showing positive inflows across most investor sizes except extra‑large. Analyst sentiment is neutral, with one Buy, one Neutral and one Sell, and historically low win rates, creating mixed confidence.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
33%
Hold
0%
Sell
33%
Strong Sell
0%
Andrew MokSell
Date2026-02-27
InstitutionBarclays
Times predicted4
Historical Win Rate75.0%
Daniel GrosslightNeutral
Stephen BaxterBuy
Is money flowing into or out of AGL?
- AGL holds a Bearish analyst rating, with 33% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 4.78/10 (Netural).
